Prof. Ali Mohammad Sharifi is a scholar with over 27 years of experience in Molecular Pharmacology at the Iran University of Medical Sciences and currently joined as a professor of regenerative Medicine in the Tissue Engineering Group at NOCERAL, department of Orthopedics Surgery, School of Medicine. He obtained his Ph.D. from the University of Glasgow in 1992 and in 2018, he further enriched his expertise by acquiring a Tissue Banking Diploma from the National University of Singapore. Throughout his career, Prof. Sharifi has undertaken international research, including working at McGill University in Canada and at Max Plank Institute in Germany. His research output includes over 100 publications in high-impact journals, along with several patented innovations. He has held various administrative and editorial roles in academia, and has served as a peer reviewer for numerous high-impact journals. His dedication to education is evident through his mentorship of undergraduate and postgraduate students, particularly Ph.D. candidates specializing in molecular medicine, tissue engineering, molecular pharmacology, and cell therapy.  Prof. Sharifi's research expertise involves the fields of cell therapy and regenerative Pharmacology, with a particular emphasis on translational medicine. His extensive body of work includes pioneering studies on pharmacological priming, therapeutic angiogenesis, and innovative strategies to enhance the effectiveness of stem cell therapy by manipulating HIF-1α stabilization, especially in the context of diabetes. Additionally, his research activities include bone and cartilage regeneration, employing a diverse array of strategies such as stem cells and biologically derived products like amniotic membrane extract and mesenchymal stem cell-derived secretome. He has also explored the potential of herbal agents in regenerative medicine.  His contributions extend to the development of custom-made bio-implants for addressing large bone defects and the design and production of various wound dressings, with a specific focus on diabetic wound healing. In recent times, Prof. Sharifi has harnessed the transformative power of CRISPR gene editing technology to combat synovial fibrosis induced by osteoarthritis. In summary, Professor Sharifi is an active scientist in the field of Molecular Pharmacology and Regenerative Medicine, exemplifying innovation, and dedication to advancing scientific knowledge for improvement of healthcare and human well-being.  

Dr. Woon Kai Lin obtained his PhD in University of Hull in photonic liquid crystal. After graduation, he worked as a postdoc in electroluminescent liquid crystalline light emitting display capable of producing 3D image funded by a start-up company and venture capitalists. He also spent a year as a Postdoc in Oxford University to study whether photonic crystals in nature can be adopted for industrial application. Later, he returned to Malaysia to work as OLED (organic light emitting diode) materials and device specialist under OSRAM. The project initially focussed in passive matrix OLED display and then later in OLED lighting using solution processable techniques. The works involved co-operation with well-known multinational companies such as Mercks, Sumitomo and Philips.  Later he joined University Malaya working in the field of organic electronics specializing in organic light emitting diode. The works including leading cost effective  synthesis of organic semiconducting materials for lighting application, interfacial physics and fundamental mechanism of high performance OLED, accurate computation of OLED materials, organic field effect transistors and phototransistors.  Some of the works carried out in the University of Malaya involves co-operating with various universities in the world, domestic and overseas start-ups and local SMEs. He is actively filing patents in the field of organic electronics.The ultimate aim is to enhance the performance to price ratio for organic electronics by investigating and optimizing critical parameters and mechanism in organic devices using various analytical and processing tools available domestically and internationally including the use of synchrotron facilities.He is also the  material science program co-ordinator setting new undergraduate Material science lab and program. Material Science under Physics department has been ranked the best in Malaysia and Faculty of Science.

Dr. Chui Ping Lei is a registered nurse, completed her Master of Medical Science (Nursing) in 2008, and joined the Department of Nursing Science in 2010. In 2015, she obtained her Ph.D. from the University of Malaya. Apart from teaching undergraduate and postgraduate students, she has been involved in curriculum development/review, coordinating the Master of Nursing Science Program, and serving as an external examiner for program improvement. She is active in research work. Her research interests are cancer care (quality of life, symptom burden/management, CAM, patient education), complementary integrative therapy (oral cryotherapy, mindful breathing, mind-body practices, kangaroo mother care), and issues related to nurses/ nursing education/ nursing management (health behavior, professional quality of life, workplace violence, information literacy, teaching-learning), stoma care, wound care, and adult/ neonatal nursing care. She has published extensively in international peer-reviewed journals. Dr. Chui has been awarded the Universiti Malaya Excellence Award for Ph.D. Graduated in 2015,  Certificate of Excellence Service 2022, Excellence Service Award 2019 & 2023, and Asian University Alliance Scholar in 2020.